Page last updated: 2024-08-05 11:46:51

caprolactams

A lactam in which the amide bond is contained within a seven-membered ring, which includes the amide nitrogen and the carbonyl carbon.

ChEBI ID: 23000

Members (7)

MemberDefinitionRole
(5R)-5-tert-butyl-1-[(3S)-3-[(4-methylphenyl)thio]-3-phenylpropyl]-2-azepanone(5R)-5-tert-butyl-1-[(3S)-3-[(4-methylphenyl)thio]-3-phenylpropyl]-2-azepanone
(5R)-5-tert-butyl-1-[(3S)-3-phenyl-3-(phenylthio)propyl]-2-azepanone(5R)-5-tert-butyl-1-[(3S)-3-phenyl-3-(phenylthio)propyl]-2-azepanone
alsterpaulloneAn organic heterotetracyclic compound that is 1,3-dihydro-2H-1-benzazepin-2-one which shares its 4-5 bond with the 3-2 bond of 5-nitro-1H-indole.alsterpaullone
ANA-12A secondary carboxamide that is anthranilic acid in which the carboxy group has undergone condensation with the primary amino group of alpha-amino-epsilon-caprolactam, while the aryl-amino group has undergone condensation with the carboxy group of 1-benzothiophene-2-carboxylic acid. It is a selective, non-competitive antagonist of tropomyosin receptor kinase B (TrkB, also known as tyrosine receptor kinase B).ANA-12
caprolactamA member of the class of caprolactams that is azepane substituted by an oxo group at position 2.epsilon-caprolactam
ciliatamide aA lipopeptide that contains N-methylphenylalanine and lysine as the amino acid residues linked to a dec-9-enoyl moiety via an amide linkage (the R,R stereoisomer). It is isolated from the deep sea sponge Aaptos ciliata and exhibits antileishmanial activity.ciliatamide A
rucaparibA member of the class of azepinoindoles that is 1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one carrying additional 4-[(methylamino)methyl]phenyl and fluoro substituents at positions 2 and 8 respectively. It is an inhibitor of poly (ADP-ribose) polymerase and is used (as the camsylate salt) as monotherapy for advanced ovarian cancer and deleterious germline or somatic BRCA mutation.rucaparib

Research

Studies (1,005)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990216 (21.49)18.7374
1990's48 (4.78)18.2507
2000's169 (16.82)29.6817
2010's400 (39.80)24.3611
2020's172 (17.11)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials42 (3.80%)5.53%
Reviews64 (5.80%)6.00%
Case Studies28 (2.54%)4.05%
Observational3 (0.27%)0.25%
Other967 (87.59%)84.16%